DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



The Effects of Gonadotropin Replacement Therapy in Patients With Hypogonadism

Information source: Gulhane School of Medicine
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Idiopathic Hypogonadotropic Hypogonadism

Intervention: hCG 1500 IU three times a week (Drug); Pregnyl (hCG) ampule 1500 IU/three times a week (Drug)

Phase: N/A

Status: Completed

Sponsored by: Gulhane School of Medicine

Official(s) and/or principal investigator(s):
Fahri Bayram, Proffesor, Study Director, Affiliation: Erciyes University School of Medicine Depatment of Endocrinology and Metabolism Kayseri TURKEY

Summary

Effects of hCG replacement therapy on metabolic syndrome parameters in hypogonadotrophic hypogonadism.

Clinical Details

Study design: Observational Model: Case-Only, Time Perspective: Prospective

Primary outcome:

HDL after hCG treatment

LDL levels after hCG treatment

total cholesterole levels after hCG treatment

Secondary outcome:

Body fat ratio after hCG treatment

hsCRP levels after hCG treatment

Eligibility

Minimum age: 16 Years. Maximum age: 45 Years. Gender(s): Male.

Criteria:

Inclusion Criteria: Serum testosterone concentration < 300ng/dL Absence of a pituitary or

hypothalamic mass lesions, Presence of gonadotropin response to GnRH, -

Exclusion Criteria: Previous androgen treatment, diabetes mellitus, arterial hypertension other hormone deficiencies

-

Locations and Contacts

Gulhane School of Medicine Dep. of Endocrinology and Metabolism, Ankara 06018, Turkey
Additional Information

Starting date: January 2011
Last updated: January 22, 2014

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017